Related Experiment Video
Updated: May 9, 2025

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Evaluation of the Space GlucoseControl System for Managing Stress-Induced Hyperglycemia in ICU Patients: Efficacy and
Peng-Cheng Liu1, Dan-Dan Fan2, Qun-Ying Bao3
1Blood Purification Center, The Second Affiliated Hospital of Soochow University, Suzhou, 215004, Jiangsu Province, China.
Background:
Despite the increasing adoption of the Space GlucoseControl system (SGCs), a novel blood glucose management technique, in critically ill patients, its efficacy and safety warrant further investigation.
Objective:
This study aimed to assess the efficacy and safety of SGCs in managing patients with stress-induced hyperglycemia in the intensive care unit.
Methods:
A prospective study was conducted involving 22 patients with stress-induced hyperglycemia monitored using the SGCs for 72 hours. Measurements included mean blood glucose, maximum blood glucose, minimum blood glucose, and frequencies of hyperglycemia (> 8.3 mmol/L), hypoglycemia (< 4.4 mmol/L), and target blood glucose (4.4 - 8.3 mmol/L).
Results:
Mean blood glucose level was significantly different at 24 hours and 48 hours and 24 hours and 72 hours with SGCs (24h vs 48h, P=0.0289; 24h vs 72h, P=0.0252). The times of hyperglycemia (> 8.3 mmol/L) (24h vs 48h, P=0.0289; 24h vs 72h, P=0.0216) was significantly reduced at 48 hours and 72 hours compared to 24 hours. The average interval between blood glucose measurements was significantly extended at 48 hours and 72 hours compared to 24 hours (24h vs 48h, P=0.0037; 24h vs 72h, P=0.0332). The frequency of target blood glucose (4.4 - 8.3 mmol/L) under SGCs blood glucose management at 48 hours and 72 hours was significantly higher than at 24 hours (24h vs 48h, P=0.0395; 24h vs 72h, P=0.0379). There was no significant difference in the times of hypoglycemia (< 4.4 mmol/L) and the highest blood glucose values between 24 hours, 48 hours, and 72 hours with SGCs glucose management (P>0.05). These findings indicate that SGCs blood glucose management can promote greater stability in the blood glucose levels of patients and alleviate the workload of medical staff to some extent.
Conclusion:
SGCs is effective in stabilizing blood glucose levels, increasing the frequency of target blood glucose values, and thereby reducing significant glucose fluctuations, which can improve patient recovery outcomes. Additionally, prolonged use of the SGCs not only optimizes glucose management but also significantly alleviates the workload of nursing staff, enhancing efficiency and allowing for more focused patient care.
More Related Videos
06:21Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
Published on: April 7, 2023
07:35Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique
Published on: January 26, 2024
Related Concept Videos
Hypoglycemia and Glucagon
Glucose Homeostasis: Regulation of Blood Glucose
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...